Yazaki, M., Nabeta, T., Inomata, T., Maemura, K., Ooki, T., Fujita, T., . . . Ako, J. (2019). Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure. Circ Rep.
Citação norma ChicagoYazaki, Mayu, et al. "Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure." Circ Rep 2019.
MLA citiranjeYazaki, Mayu, et al. "Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure." Circ Rep 2019.
Opozorilo: Ti citati niso vedno 100% točni.